S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13

GeoVax Labs Stock Forecast, Price & News

-0.23 (-5.87%)
(As of 12/3/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
501,748 shs
Average Volume
2.71 million shs
Market Capitalization
$23.54 million
P/E Ratio
Dividend Yield
30 days | 90 days | 365 days | Advanced Chart
Receive GOVX News and Ratings via Email

Sign-up to receive the latest news and ratings for GeoVax Labs and its competitors with MarketBeat's FREE daily newsletter.

GeoVax Labs logo

About GeoVax Labs

GeoVax Labs, Inc. is a clinical-stage biotechnology company, which engages in the development of immunotherapies and vaccines against cancers and infectious diseases using a novel vector vaccine platform. It focuses on preventive vaccines against hemorrhagic fever viruses such as Ebola, Sudan, Marburg, and Lassa fever; Zika virus and malari; human immunodeficiency virus (HIV); as well as immunotherapies for solid tumor cancers. The company was founded in June 1988 and is headquartered in Smyrna, GA.


See More Headlines

Industry, Sector and Symbol

Pharmaceutical preparations
Current Symbol
Year Founded

Sales & Book Value

Annual Sales
$1.82 million
Book Value
$2.82 per share


Net Income
$-2.96 million
Net Margins
Pretax Margin




Free Float
Market Cap
$23.54 million
Not Optionable

Company Calendar

Last Earnings
Fiscal Year End
Next Earnings (Estimated)


Overall MarketRank

1.70 out of 5 stars

Medical Sector

939th out of 1,388 stocks

Pharmaceutical Preparations Industry

447th out of 668 stocks

Analyst Opinion: 3.5Community Rank: 5.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

GeoVax Labs (NASDAQ:GOVX) Frequently Asked Questions

Is GeoVax Labs a buy right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for GeoVax Labs in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" GeoVax Labs stock.
View analyst ratings for GeoVax Labs
or view top-rated stocks.

How has GeoVax Labs' stock been impacted by COVID-19?

GeoVax Labs' stock was trading at $0.28 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, GOVX shares have increased by 1,217.9% and is now trading at $3.69.
View which stocks have been most impacted by COVID-19

Are investors shorting GeoVax Labs?

GeoVax Labs saw a decline in short interest in the month of November. As of November 15th, there was short interest totaling 199,400 shares, a decline of 43.2% from the October 31st total of 351,000 shares. Based on an average daily trading volume, of 1,140,000 shares, the days-to-cover ratio is presently 0.2 days. Approximately 3.3% of the company's stock are sold short.
View GeoVax Labs' Short Interest

When is GeoVax Labs' next earnings date?

GeoVax Labs is scheduled to release its next quarterly earnings announcement on Tuesday, March 22nd 2022.
View our earnings forecast for GeoVax Labs

How were GeoVax Labs' earnings last quarter?

GeoVax Labs, Inc. (NASDAQ:GOVX) announced its quarterly earnings results on Thursday, November, 11th. The company reported ($0.31) earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of ($0.37) by $0.06. GeoVax Labs had a negative trailing twelve-month return on equity of 36.51% and a negative net margin of 1,305.93%.
View GeoVax Labs' earnings history

What price target have analysts set for GOVX?

1 analysts have issued twelve-month price targets for GeoVax Labs' stock. Their forecasts range from $10.00 to $10.00. On average, they expect GeoVax Labs' stock price to reach $10.00 in the next twelve months. This suggests a possible upside of 171.0% from the stock's current price.
View analysts' price targets for GeoVax Labs
or view top-rated stocks among Wall Street analysts.

Who are GeoVax Labs' key executives?

GeoVax Labs' management team includes the following people:
  • David A. Dodd, Chairman, President & Chief Executive Officer
  • Mark W. Reynolds, Chief Financial Officer & Secretary
  • Harriet Latham Robinson, Chief Scientific Officer-Emeritus
  • Mark J. Newman, Chief Scientific Officer

What is GeoVax Labs' stock symbol?

GeoVax Labs trades on the NASDAQ under the ticker symbol "GOVX."

Who are GeoVax Labs' major shareholders?

GeoVax Labs' stock is owned by a number of retail and institutional investors. Top institutional investors include Geode Capital Management LLC (0.93%), GSA Capital Partners LLP (0.65%), Squarepoint Ops LLC (0.18%) and Two Sigma Securities LLC (0.18%). Company insiders that own GeoVax Labs stock include David A Dodd, Mark Reynolds and Randal D Chase.
View institutional ownership trends for GeoVax Labs

Which institutional investors are buying GeoVax Labs stock?

GOVX stock was acquired by a variety of institutional investors in the last quarter, including GSA Capital Partners LLP, Squarepoint Ops LLC, Two Sigma Securities LLC, and Geode Capital Management LLC. Company insiders that have bought GeoVax Labs stock in the last two years include David A Dodd, Mark Reynolds, and Randal D Chase.
View insider buying and selling activity for GeoVax Labs
or or view top insider-buying stocks.

How do I buy shares of GeoVax Labs?

Shares of GOVX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is GeoVax Labs' stock price today?

One share of GOVX stock can currently be purchased for approximately $3.69.

How much money does GeoVax Labs make?

GeoVax Labs has a market capitalization of $23.54 million and generates $1.82 million in revenue each year.

How many employees does GeoVax Labs have?

GeoVax Labs employs 8 workers across the globe.

What is GeoVax Labs' official website?

The official website for GeoVax Labs is www.geovax.com.

Where are GeoVax Labs' headquarters?

GeoVax Labs is headquartered at 1900 LAKE PARK DRIVE SUITE 380, SMYRNA GA, 30080.

How can I contact GeoVax Labs?

GeoVax Labs' mailing address is 1900 LAKE PARK DRIVE SUITE 380, SMYRNA GA, 30080. The company can be reached via phone at (678) 384-7220, via email at [email protected], or via fax at 678-384-7281.

This page was last updated on 12/4/2021 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.